Breaking News, Financial News

Financial Report: Covance

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Covance 1Q Revenues: $376.9 million (+13%) 1Q Earnings: $38.9 million (+16%) Comments: Operating income for the quarter increased 23% to $43.7 million. Late-Stage Development revenue was flat at $179.1 million. Early Development revenue was $179.2 million, up 26%. Net orders were up 36% in the quarter to $510 million. Backlog grew 39% to $2.4 billion in the quarter....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters